Search

everythinglearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Restoring nerve-macrophage communication may help treat autoimmune diseases.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

IL-15 promotes hair growth and protects hair follicles.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The role of γδT-cells in causing alopecia areata remains unclear.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Rosemary extract may boost the immune system, but more research on humans is needed to confirm this.

Different γδ T cell types have unique roles in causing alopecia areata.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

IL-10 may worsen alopecia areata instead of helping it.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

The skin plays a key role in immune responses and reflects emotional and stress reactions.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.